Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 28;16(5):e0249883.
doi: 10.1371/journal.pone.0249883. eCollection 2021.

Impact of influenza vaccination in the Netherlands, 2007-2016: Vaccinees consult their general practitioner for clinically diagnosed influenza, acute respiratory infections, and pneumonia more often than non-vaccinees

Affiliations

Impact of influenza vaccination in the Netherlands, 2007-2016: Vaccinees consult their general practitioner for clinically diagnosed influenza, acute respiratory infections, and pneumonia more often than non-vaccinees

Saverio Caini et al. PLoS One. .

Abstract

Introduction: We aimed to develop an innovative population-based method to estimate the health effect of influenza vaccination based on electronic medical records collected within a general practitioner (GP)-based influenza surveillance system in the Netherlands.

Methods: In each season between 2006/07 and 2015/16, we fitted multilevel Poisson regression models to compare GP consultation rates for clinically diagnosed influenza, acute respiratory infections (ARI), pneumonia, and lower back pain (as a control) between vaccinated vs. unvaccinated individuals. Season-specific relative risks and 95% confidence intervals (CI) were pooled into summary risk ratio (SRR) through random-effects meta-analysis models. Analyses were stratified by patient age (<45, 45-59, 60-74, ≥75 years) and medical indication for the vaccine (any vs. none, subjects aged ≤60 years only).

Results: Overall, 12.6% and 21.4% of study subjects were vaccinated because of their age only or because of an underlying medical condition. Vaccine uptake declined over time, especially among subjects aged ≤74 years with medical indications for vaccination. Vaccinated individuals had significantly higher GP consultation rates for clinically diagnosed influenza (SRR 1.24, 95% CI 1.12-1.38, p-value <0.001), ARI (SRR 1.33, 95% CI 1.27-1.39, p-value <0.001), pneumonia (SRR 1.27, 95% CI 1.19-1.36, p-value <0.001), and lower back pain (SRR 1.21, 95% CI 1.14-1.28, p-value <0.001) compared to unvaccinated individuals.

Discussion: Contrary to expectations, influenza vaccinees have GP consultation rates for clinically diagnosed influenza, ARI and pneumonia that are 24-33% higher compared to unvaccinated individuals. The lower back pain finding suggests that the increase in consultation rates is partially caused by confounding. Importantly, considering the data are not laboratory-confirmed, our results cannot be linked directly to influenza, but only to respiratory illnesses in general.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Association between influenza vaccination and the risk of influenza according to age group and presence of medical indication.
Summary risk ratio (SRR) and 95% confidence intervals (CI) were calculated by pooling season-specific risk ratio using random effects meta-analysis models; between-seasons heterogeneity was quantified using the I2 statistics (see text for details; season-specific risk ratio were provided in S1 Table). The Netherlands, seasons 2006/07 to 2015/16.
Fig 2
Fig 2. Association between influenza vaccination and the risk of acute respiratory infection according to age group and presence of medical indication.
Summary risk ratio (SRR) and 95% confidence intervals (CI) were calculated by pooling season-specific risk ratio using random effects meta-analysis models; between-seasons heterogeneity was quantified using the I2 statistics (see text for details; season-specific risk ratio were provided in S2 Table). The Netherlands, seasons 2006/07 to 2015/16.
Fig 3
Fig 3. Association between influenza vaccination and the risk of pneumonia according to age group and presence of medical indication.
Summary risk ratio (SRR) and 95% confidence intervals (CI) were calculated by pooling season-specific risk ratio using random effects meta-analysis models; between-seasons heterogeneity was quantified using the I2 statistics (see text for details; season-specific risk ratio were provided in S3 Table). The Netherlands, seasons 2006/07 to 2015/16.
Fig 4
Fig 4. Association between influenza vaccination and the risk of lower back pain according to age group and presence of medical indication.
Summary risk ratio (SRR) and 95% confidence intervals (CI) were calculated by pooling season-specific risk ratio using random effects meta-analysis models; between-seasons heterogeneity was quantified using the I2 statistics (see text for details; season-specific risk ratio were provided in S4 Table). The Netherlands, seasons 2006/07 to 2015/16.

References

    1. GBD 2017 Influenza Collaborators. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2019;7(1):69–89. 10.1016/S2213-2600(18)30496-X - DOI - PMC - PubMed
    1. World Health Organization (WHO). Regional office for Europe. Influenza vaccination. Available from: http://www.euro.who.int/en/health-topics/communicable-diseases/influenza....
    1. European Centre for Disease Prevention and Control (ECDC). Risk groups for severe influenza. Available from: https://ecdc.europa.eu/en/seasonal-influenza/prevention-and-control/vacc....
    1. Hekimoğlu CH, Emek M, Avcı E, Topal S, Demiröz M, Ergör G. Seasonal influenza vaccine effectiveness in preventing laboratory confirmed influenza in 2014–2015 season in Turkey: a test-negative case control study. Balkan Med J. 2018;35(1):77–83. 10.4274/balkanmedj.2017.0487 - DOI - PMC - PubMed
    1. De Serres G, Skowronski DM, Wu XW, Ambrose CS. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials. Euro Surveill. 2013;18(37). 10.2807/1560-7917.es2013.18.37.20585 - DOI - PubMed

Substances

LinkOut - more resources